You are here: All Products  > Antengene Completes $120 Million Series B for China Clinical Trials

Antengene Completes $120 Million Series B for China Clinical Trials

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products